Karyopharm Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of KPTI for the last quarter is 33.75 M USD, and it's 6.28% lower compared to the previous quarter. The net income of Q4 23 is -41.84 M USD.